InvestorsHub Logo
Followers 800
Posts 50862
Boards Moderated 2
Alias Born 12/12/2004

Re: None

Thursday, 12/31/2015 9:22:21 AM

Thursday, December 31, 2015 9:22:21 AM

Post# of 1059
PACB : Drugs giant GlaxoSmithKline eased 7.5p to 1384p amid speculation it had been stalking Pacific Bioscience of California, which traded a fraction easier at $13.40 in New York, but is about to lose out to rival Roche which already has a collaboration agreement with PACB. Dealers heard a take-out price could be around $20 a share

Read more: http://www.thisismoney.co.uk/money/markets/article-3379214/MARKET-REPORT-Vodafone-said-planning-possible-140bn-merger-listed-cable-company-Liberty-Global-early-2016.html#ixzz3vu8BauoV

DUKE BASKETBALL and NOTRE DAME FOOTBALL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PACB News